Search
Browse
Statistics
Feeds

Proneural-mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
2MB
[thumbnail of Supplementary Data] Other (Supplementary Data)
48MB

Item Type:Article
Title:Proneural-mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import
Creators Name:Bourmeau, Guillaume, Anezo, Oceane, Raymond, Jeremy, Ballestín, Alberto, Pichol-Thievend, Cathy, Reveilles, Juliette, Thomas, Adrien, Wang, Lin, Miranda, Melanie, Moutaux, Eve, Liva, Stephane, Ribecco, Valentino, Besse, Laetitia, Dingli, Florent, Loew, Damarys, Vallot, Celine, Gargiulo, Gaetano, Ravi, Vidhya M., Joseph, Kevin and Seano, Giorgio
Abstract:BACKGROUND: Despite extensive research efforts, glioblastoma (GBM) remains a deadly disease with poor prognosis. Although previous studies have identified various cell states within GBM tumors, the molecular mechanism underlying adaptive GBM cell plasticity induced by conventional therapy remains unclear. METHODS: We used fluorescent reporters for proneural (PN) and mesenchymal (MES) subtypes to monitor GBM cell plasticity in real-time across multiple patient-derived cell lines. This approach revealed cells that concurrently expressed both PN and MES markers. To investigate this unique hybrid population, we implemented a comprehensive methodological approach encompassing bulk and single-cell RNA sequencing, single-cell ChIP sequencing, nuclear proteomics, high-resolution imaging, orthotopic mouse models, clinical dataset analysis, and pharmacological and genetic techniques. This multifaceted strategy allowed us to gain functional and molecular insights into this distinct cellular population. RESULTS: We showed that these hybrid cells are increased by conventional therapies, and are resistant to these therapies. At the molecular level, hybrid cells display significant alterations in chromatin structure and nuclear protein composition, elevated transcriptional activity, Myc activation, and improved transport between the nucleus and cytoplasm. Genetic and pharmaceutical inhibition of the nuclear import/export shuttling machinery, increased in hybrid cells, effectively suppressed adaptive GBM cell plasticity and hybrid identity, thereby enhancing the sensitivity of GBM cells to therapies. CONCLUSIONS: Our results indicate that GBM hybrid cells play a crucial role in chemoradiation resistance. The nuclear transport machinery presents a potential therapeutic target for hybrid cells, offering a way to counteract the typical resistance to treatment observed in GBM.
Keywords:Cell Plasticity, Glioblastoma, Hybrid, Nuclear Transport, Resistance Mechanisms, Animals, Mice
Source:Neuro-Oncology
ISSN:1522-8517
Publisher:Oxford University Press
Volume:27
Number:11
Page Range:2876-2893
Date:November 2025
Additional Information:ProteomeXchange dataset PXD050217 has been reserved by the PRIDE repository for a dataset that has been deposited, but is not yet publicly released and announced to ProteomeXchange.
Official Publication:https://doi.org/10.1093/neuonc/noaf160
PubMed:View item in PubMed
Related to:

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library